Pakhsh Alborz Company (PAKHSH) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- PAKHSH
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 394,330,511 | 208,771,817 | 116,772,488 | 98,974,760 | 55,164,323 | 35,739,177 |
| Cost of operating revenue | -347,526,345 | -186,878,245 | -104,116,817 | -88,922,705 | -48,741,049 | -31,555,671 |
| Gross profit (loss) | 46,804,166 | 21,893,572 | 12,655,671 | 10,052,055 | 6,423,274 | 4,183,506 |
| Selling, general and administrative expenses | -17,132,068 | -10,243,639 | -7,271,021 | -5,085,026 | -3,151,245 | -1,878,746 |
| Operating profit (loss) | 29,672,098 | 10,722,649 | 5,384,650 | 4,967,029 | 3,272,029 | 2,253,910 |
| Finance costs | -8,161,387 | -2,312,956 | -1,501,242 | -1,128,675 | -725,344 | -560,721 |
| Other non-operating income and expenses | 654,642 | 34,757 | 28,487 | 35,752 | 172,959 | 422,657 |
| Profit (loss) from continuing operations before tax | 22,165,353 | 8,444,450 | 3,911,895 | 3,874,106 | 2,719,644 | 2,115,846 |
| Current year tax | -4,983,015 | -1,894,709 | -924,501 | -771,738 | -505,133 | -423,035 |
| Net profit (loss) from continuing operations | 17,182,338 | 6,549,741 | 2,987,394 | 3,102,368 | 2,214,511 | 1,626,851 |
| Net profit (loss) | 17,182,338 | 6,549,741 | 2,987,394 | 3,102,368 | 2,214,511 | 1,626,851 |
| Basic earnings (loss) per share | 1,719 rials | 758 rials | 442 rials | 839 rials | 1,587 rials | 1,177 rials |
| Net earnings (loss) per share, rials | 1,719 rials | 759 rials | 440 rials | 1,293 rials | 1,582 rials | 1,713 rials |
| Capital | 10,000,000 | 8,640,000 | 6,800,000 | 2,400,000 | 1,400,000 | 950,000 |
Reporting periods
64 periods are on file for this report, from the period ending 1390/12/29 to the period ending 1405/06/31.